OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism
Wei Xie, Lei Lei, Yue Xu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 518, Iss. 1, pp. 120-126
Closed Access | Times Cited: 138
Wei Xie, Lei Lei, Yue Xu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 518, Iss. 1, pp. 120-126
Closed Access | Times Cited: 138
Showing 1-25 of 138 citing articles:
The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1400
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1400
METTL3 plays multiple functions in biological processes.
Shuiping Liu, Lvjia Zhuo, Jianjun Wang, et al.
PubMed (2020) Vol. 10, Iss. 6, pp. 1631-1646
Closed Access | Times Cited: 160
Shuiping Liu, Lvjia Zhuo, Jianjun Wang, et al.
PubMed (2020) Vol. 10, Iss. 6, pp. 1631-1646
Closed Access | Times Cited: 160
Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma
Yeming Yang, Jingshu Cai, Xue Yang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2342-2353
Open Access | Times Cited: 118
Yeming Yang, Jingshu Cai, Xue Yang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2342-2353
Open Access | Times Cited: 118
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2
Epitranscriptomics in liver disease: Basic concepts and therapeutic potential
Zhicong Zhao, Jiaxiang Meng, Rui Su, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 664-679
Open Access | Times Cited: 128
Zhicong Zhao, Jiaxiang Meng, Rui Su, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 664-679
Open Access | Times Cited: 128
Principles of RNA methylation and their implications for biology and medicine
Yujia Zhou, Ying Kong, Wenguo Fan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110731-110731
Open Access | Times Cited: 101
Yujia Zhou, Ying Kong, Wenguo Fan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110731-110731
Open Access | Times Cited: 101
The METTL3/MALAT1/PTBP1/USP8/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis
Bo Shu, Yingxia Zhou, Hao Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 99
Bo Shu, Yingxia Zhou, Hao Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 99
The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
Xinzhi Li, Bingchuan Yuan, Min Lü, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Xinzhi Li, Bingchuan Yuan, Min Lü, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
The evolving landscape of N6-methyladenosine modification in the tumor microenvironment
Yunru Gu, Xi Wu, Jingxin Zhang, et al.
Molecular Therapy (2021) Vol. 29, Iss. 5, pp. 1703-1715
Open Access | Times Cited: 87
Yunru Gu, Xi Wu, Jingxin Zhang, et al.
Molecular Therapy (2021) Vol. 29, Iss. 5, pp. 1703-1715
Open Access | Times Cited: 87
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
Beijian Zhang, Hao Jiang, Zhen Dong, et al.
Genes & Diseases (2020) Vol. 8, Iss. 6, pp. 746-758
Open Access | Times Cited: 84
Beijian Zhang, Hao Jiang, Zhen Dong, et al.
Genes & Diseases (2020) Vol. 8, Iss. 6, pp. 746-758
Open Access | Times Cited: 84
METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
Zishan Peng, Yingying Gong, Xuejie Wang, et al.
Molecular Therapy (2021) Vol. 30, Iss. 2, pp. 932-946
Open Access | Times Cited: 76
Zishan Peng, Yingying Gong, Xuejie Wang, et al.
Molecular Therapy (2021) Vol. 30, Iss. 2, pp. 932-946
Open Access | Times Cited: 76
METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho
Manna Li, Le Deng, Gaosi Xu
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 75
Manna Li, Le Deng, Gaosi Xu
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 75
Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart
Zujie Xu, Ying Qin, Binbin Lv, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 251-251
Open Access | Times Cited: 46
Zujie Xu, Ying Qin, Binbin Lv, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 251-251
Open Access | Times Cited: 46
Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a
Yan Xu, Zhuowei Zhou, Xinmei Kang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Yan Xu, Zhuowei Zhou, Xinmei Kang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders
Samradhi Singh, Devojit Kumar Sarma, Vinod Verma, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 1-20
Closed Access | Times Cited: 40
Samradhi Singh, Devojit Kumar Sarma, Vinod Verma, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 1-20
Closed Access | Times Cited: 40
The role of RNA m6A methylation in lipid metabolism
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA
Yong Zhang, Xiaonan Chen, Hong Zhang, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 12, pp. 2462-2476
Closed Access | Times Cited: 31
Yong Zhang, Xiaonan Chen, Hong Zhang, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 12, pp. 2462-2476
Closed Access | Times Cited: 31
N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10
Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 9
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 9
m6A Regulates Liver Metabolic Disorders and Hepatogenous Diabetes
Yuhuan Li, Qingyang Zhang, Guanshen Cui, et al.
Genomics Proteomics & Bioinformatics (2020) Vol. 18, Iss. 4, pp. 371-383
Open Access | Times Cited: 69
Yuhuan Li, Qingyang Zhang, Guanshen Cui, et al.
Genomics Proteomics & Bioinformatics (2020) Vol. 18, Iss. 4, pp. 371-383
Open Access | Times Cited: 69
m6A RNA Methylation: Ramifications for Gene Expression and Human Health
R. Karthiya, Piyush Khandelia
Molecular Biotechnology (2020) Vol. 62, Iss. 10, pp. 467-484
Open Access | Times Cited: 60
R. Karthiya, Piyush Khandelia
Molecular Biotechnology (2020) Vol. 62, Iss. 10, pp. 467-484
Open Access | Times Cited: 60
Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases
Emma Wilkinson, Yan‐Hong Cui, Yu‐Ying He
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1949-1949
Open Access | Times Cited: 48
Emma Wilkinson, Yan‐Hong Cui, Yu‐Ying He
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1949-1949
Open Access | Times Cited: 48
The potential role of m6A RNA methylation in diabetic retinopathy
Nidhi Kumari, Aditi Karmakar, Md Maqsood Ahamad Khan, et al.
Experimental Eye Research (2021) Vol. 208, pp. 108616-108616
Closed Access | Times Cited: 43
Nidhi Kumari, Aditi Karmakar, Md Maqsood Ahamad Khan, et al.
Experimental Eye Research (2021) Vol. 208, pp. 108616-108616
Closed Access | Times Cited: 43
